HomeCompareHROWL vs DGRO

HROWL vs DGRO: Dividend Comparison 2026

HROWL yields 6.31% · DGRO yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DGRO wins by $1.3K in total portfolio value· pulled ahead in Year 5
10 years
HROWL
HROWL
● Live price
6.31%
Share price
$25.61
Annual div
$1.62
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.4K
Annual income
$943.95
Full HROWL calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.13%
Share price
$68.98
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$239.96
Full DGRO calculator →

Portfolio growth — HROWL vs DGRO

📍 DGRO pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHROWLDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HROWL + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HROWL pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HROWL
Annual income on $10K today (after 15% tax)
$536.74/yr
After 10yr DRIP, annual income (after tax)
$802.36/yr
DGRO
Annual income on $10K today (after 15% tax)
$181.24/yr
After 10yr DRIP, annual income (after tax)
$203.97/yr
At 15% tax rate, HROWL beats the other by $598.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HROWL + DGRO for your $10,000?

HROWL: 50%DGRO: 50%
100% DGRO50/50100% HROWL
Portfolio after 10yr
$31.0K
Annual income
$591.95/yr
Blended yield
1.91%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HROWL buys
0
DGRO buys
0
No recent congressional trades found for HROWL or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHROWLDGRO
Forward yield6.31%2.13%
Annual dividend / share$1.62$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$30.4K$31.6K
Annual income after 10y$943.95$239.96
Total dividends collected$7.9K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: HROWL vs DGRO ($10,000, DRIP)

YearHROWL PortfolioHROWL Income/yrDGRO PortfolioDGRO Income/yrGap
1$11,331$631.46$11,293$213.22+$38.00HROWL
2$12,793$668.73$12,730$217.32+$63.00HROWL
3$14,395$705.61$14,326$221.10+$69.00HROWL
4$16,144$741.99$16,098$224.56+$46.00HROWL
5← crossover$18,052$777.73$18,064$227.74$12.00DGRO
6$20,128$812.75$20,246$230.65$118.00DGRO
7$22,384$846.94$22,666$233.30$282.00DGRO
8$24,831$880.25$25,349$235.73$518.00DGRO
9$27,482$912.60$28,325$237.94$843.00DGRO
10$30,350$943.95$31,624$239.96$1.3KDGRO

HROWL vs DGRO: Complete Analysis 2026

HROWLStock

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Full HROWL Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this HROWL vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HROWL vs SCHDHROWL vs JEPIHROWL vs OHROWL vs KOHROWL vs MAINHROWL vs VIGHROWL vs NOBLHROWL vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.